NO20072478L - Salter av isofosforamidsennep og analoger av disse som antitumor midler - Google Patents

Salter av isofosforamidsennep og analoger av disse som antitumor midler

Info

Publication number
NO20072478L
NO20072478L NO20072478A NO20072478A NO20072478L NO 20072478 L NO20072478 L NO 20072478L NO 20072478 A NO20072478 A NO 20072478A NO 20072478 A NO20072478 A NO 20072478A NO 20072478 L NO20072478 L NO 20072478L
Authority
NO
Norway
Prior art keywords
salts
isophosphoramide mustard
analogues
methods
antitumor agents
Prior art date
Application number
NO20072478A
Other languages
English (en)
Inventor
Lee Morgan
Original Assignee
Dekk Tec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dekk Tec Inc filed Critical Dekk Tec Inc
Publication of NO20072478L publication Critical patent/NO20072478L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/222—Amides of phosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende forbindelse angår salter og preparater av isofosforamid sennep og isofosforamid sennepsanaloger. I én utførelsesform kan saltene representeres ved formelen hvor A+ representerer en ammonium type valgt fra den protonerte (konjugerte syre) eller kvaternære formen av alifatiske aminer og aromatiske aminer, omfattende basiske aminosyrer, heterocykliske aminer, substituerte og usubstituerte pyridiner, guanidiner og amidiner; og X og Y uavhengig representerer utgående grupper. Også beskrevet her er metoder for fremstilling av slike forbindelser og formulering av farmasøytiske preparater derav. Metoder for administrering av den beskrevete forbindelsen til individet, spesielt for behandling av hyperproliferative lidelser er også beskrevet heri.
NO20072478A 2004-10-25 2007-05-16 Salter av isofosforamidsennep og analoger av disse som antitumor midler NO20072478L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62208704P 2004-10-25 2004-10-25
US67270705P 2005-04-18 2005-04-18
PCT/US2005/038523 WO2006047575A2 (en) 2004-10-25 2005-10-25 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Publications (1)

Publication Number Publication Date
NO20072478L true NO20072478L (no) 2007-06-25

Family

ID=35788704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072478A NO20072478L (no) 2004-10-25 2007-05-16 Salter av isofosforamidsennep og analoger av disse som antitumor midler

Country Status (17)

Country Link
US (4) US8232262B2 (no)
EP (3) EP1805192B1 (no)
JP (1) JP5336082B2 (no)
KR (2) KR20130041384A (no)
CN (3) CN101087800B (no)
AU (1) AU2005299385B2 (no)
CA (1) CA2585125C (no)
DK (2) DK2336140T3 (no)
ES (2) ES2565929T3 (no)
HK (1) HK1209752A1 (no)
IL (3) IL182752A (no)
NO (1) NO20072478L (no)
NZ (2) NZ589418A (no)
PL (1) PL1805192T3 (no)
PT (1) PT1805192E (no)
SI (1) SI1805192T1 (no)
WO (1) WO2006047575A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2565929T3 (es) 2004-10-25 2016-04-07 Dekk-Tec, Inc. Sales de mostaza de isofosforamida y análogos de las mismas como agentes antitumorales
US7964583B2 (en) 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
ES2547302T3 (es) 2007-04-06 2015-10-05 Ziopharm Oncology, Inc. Sales de mostaza de isofosforamida y análogos de las mismas
CA2732290A1 (en) * 2008-07-31 2010-02-04 Ziopharm Oncology, Inc. Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
JP5779106B2 (ja) * 2009-02-24 2015-09-16 デック−テック， インコーポレイテッド 抗腫瘍剤としての４−ヒドロペルオキシイホスファミドの錯体
CN102659841B (zh) * 2012-04-24 2015-03-25 石家庄学院 多元酚磷酰胺衍生物及其制备方法与应用
WO2014117035A1 (en) 2013-01-24 2014-07-31 Transderm, Inc. COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS
AU2016318613A1 (en) 2015-09-10 2018-03-22 Becton, Dickinson And Company Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide
JP7108631B2 (ja) 2017-01-06 2022-07-28 パルヴェラ セラピューティクス、インク． ｍＴＯＲ阻害剤の無水組成物およびその使用方法
USD859683S1 (en) 2017-09-21 2019-09-10 Becton, Dickinson And Company Collection device
US11002642B2 (en) 2017-09-21 2021-05-11 Becton, Dickinson And Company Demarcation template for hazardous contaminant testing
WO2019060269A1 (en) 2017-09-21 2019-03-28 Becton, Dickinson And Company KIT FOR COLLECTING HAZARDOUS CONTAMINANTS AND RAPID ANALYSIS
US11391748B2 (en) 2017-09-21 2022-07-19 Becton, Dickinson And Company High dynamic range assays in hazardous contaminant testing
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
JP7520822B2 (ja) * 2018-09-25 2024-07-23 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ ２’－ハロゲン化－４’－チオ－２’－デオキシ－５－アザシチジンアナログおよびその使用
CA3125355A1 (en) 2019-01-28 2020-08-06 Becton, Dickinson And Company Hazardous contaminant collection device with integrated swab and test device
CN111973583A (zh) * 2020-07-29 2020-11-24 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 芹菜素在制备促进缺血超长随意皮瓣存活药物的作用
CN111943979B (zh) * 2020-10-19 2020-12-22 南京卓康医药科技有限公司 一种异环磷酰胺中间体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (no) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
DD260279A5 (de) * 1986-02-22 1988-09-21 Asta-Werke Ag Chemische Fabrik,De Verfahren zur herstellung heterocyclischer verbindungen mit einem 2-(2-[n,n-bis-12)2-chlorethyl)-diamido-phosphoryloxy]ethyl)-rest
US4841085A (en) * 1986-06-30 1989-06-20 Board Of Regents, University Of Texas System Aldophosphamides
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
JPH07505887A (ja) 1992-04-17 1995-06-29 アボツト・ラボラトリーズ タキソール誘導体
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
EP1185276B1 (en) 1999-05-24 2003-12-10 Southern Research Institute Isophosphoramide mustard analogs and use thereof
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
WO2001079158A2 (en) 2000-04-13 2001-10-25 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
DE10064312C2 (de) * 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
DE60330407D1 (de) 2002-08-23 2010-01-14 Sloan Kettering Inst Cancer Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
ES2565929T3 (es) 2004-10-25 2016-04-07 Dekk-Tec, Inc. Sales de mostaza de isofosforamida y análogos de las mismas como agentes antitumorales
ES2547302T3 (es) * 2007-04-06 2015-10-05 Ziopharm Oncology, Inc. Sales de mostaza de isofosforamida y análogos de las mismas
CA2732290A1 (en) * 2008-07-31 2010-02-04 Ziopharm Oncology, Inc. Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

Also Published As

Publication number Publication date
US7678778B2 (en) 2010-03-16
US20150152125A1 (en) 2015-06-04
DK2336140T3 (en) 2016-03-21
EP1805192A2 (en) 2007-07-11
CA2585125A1 (en) 2006-05-04
EP2336140A2 (en) 2011-06-22
ES2397165T3 (es) 2013-03-05
AU2005299385A1 (en) 2006-05-04
EP2336139A2 (en) 2011-06-22
NZ589418A (en) 2012-03-30
KR101292026B1 (ko) 2013-08-01
EP2336139A3 (en) 2012-01-04
IL211935A0 (en) 2011-05-31
AU2005299385B2 (en) 2011-06-16
EP1805192B1 (en) 2012-10-17
EP2336140B1 (en) 2016-01-27
NZ555323A (en) 2010-12-24
IL182752A (en) 2012-09-24
ES2565929T3 (es) 2016-04-07
DK1805192T3 (da) 2013-02-04
SI1805192T1 (sl) 2013-02-28
PL1805192T3 (pl) 2013-03-29
HK1100945A1 (en) 2007-11-16
US8232262B2 (en) 2012-07-31
KR20130041384A (ko) 2013-04-24
KR20070121632A (ko) 2007-12-27
CA2585125C (en) 2014-04-22
WO2006047575A2 (en) 2006-05-04
US20060089333A1 (en) 2006-04-27
EP2336140A3 (en) 2012-01-11
IL182752A0 (en) 2007-07-24
US20080267945A1 (en) 2008-10-30
WO2006047575A3 (en) 2006-08-10
JP5336082B2 (ja) 2013-11-06
PT1805192E (pt) 2013-01-23
US8795659B2 (en) 2014-08-05
CN103172662A (zh) 2013-06-26
JP2008517949A (ja) 2008-05-29
CN104558023A (zh) 2015-04-29
IL211936A0 (en) 2011-05-31
US20130149296A1 (en) 2013-06-13
CN101087800A (zh) 2007-12-12
US9346836B2 (en) 2016-05-24
IL211936A (en) 2012-12-31
HK1209752A1 (en) 2016-04-08
CN101087800B (zh) 2015-01-07

Similar Documents

Publication Publication Date Title
NO20072478L (no) Salter av isofosforamidsennep og analoger av disse som antitumor midler
EA200970171A1 (ru) Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
NO20085060L (no) Triazolpyrazinderivater anvendelige som anti-cancermidler
CY1112831T1 (el) Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh
MX2010008101A (es) Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica.
MX2010001005A (es) Derivados de (hetero)aril-metilen-n-cicloalquilcarboxamida condensados de 6 elementos con n como fungicidas.
EP2423207A3 (en) 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
BR0313160A (pt) Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
WO2008093024A3 (fr) Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2-carboxamides, leur préparation et leur application en therapeutique
CY1108529T1 (el) Νεα αζαδικυκλικα παραγωγα, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τα περιεχουν
NO20063062L (no) Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse
DK1476470T3 (da) Stivelsesderivater, stivelse-aktivstof-konjugater, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemidler
EA200702375A1 (ru) Производные мочевины, способы их получения и применения
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
NO20073549L (no) Fremgangsmate for fremstilling av organiske forbindelser
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
CY1112012T1 (el) Αμινουχα παραγωγα β-ομοανδροστανων και β-ετεροανδροστανων
ZA200704584B (en) New 3-Phenylpropionic acid derivatives for the treatment of diabetes
NO20063859L (no) Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter
TW200719889A (en) Amino acid derivatives
DE502004006253D1 (de) Substituierte benzoylureidopyridyl-piperidin- und -pyrrolidin-carbons urederivate, verfahren zu deren herstellung und deren v erwendung
CY1113675T1 (el) Αλατα μουσταρδας ισοφωσφοραμιδιου και αναλογα αυτων ως αντικαρκινικοι παραγοντες
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
DK1585728T3 (da) Iminosyrederivater som inhibitorer af matrix-metalloproteinaser
ZA200706705B (en) Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application